Cargando...

Prostate Cancer: Update on Early Detection and New Biomarkers

Screening and early treatment of prostate cancer (PCa) has recently come under scrutiny due to the rates of overdiagnosis of low risk cancer. Randomized trials, including ERSPC and PLCO, have informed our understanding of the survival benefit provided by systematic PCa screening with serum prostate-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mo Med
Autor principal: Grubb, Robert L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Journal of the Missouri State Medical Association 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139871/
https://ncbi.nlm.nih.gov/pubmed/30228704
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!